Morning Market Gainers

shares jumped 59.18 percent to $8.32 after the company reported positive End-of-Phase 2 meeting with the FDA and Phase 3 development strategy for trabodenoson, a novel treatment for glaucoma.

surged 31.82 percent to $16.86 on Q2 results. Flotek Industries reported a Q2 loss of $12.5 million.

shares gained 29.87 percent to $6.99 after the company reported upbeat Q2 results.

jumped 19.91 percent to $10.24. Gulfmark Offshore reported a Q2 loss of $0.27 per share on revenue of $74.5 million.

rose 19.58 percent to $37.00 after the company reported Q2 results and announced its plans to acquire CastleLine Holdings.

surged 18.24 percent to $18.73 after the company reported positive results from Phase 2 trial in uremic pruritus.

shares climbed 16.09 percent to $62.90 after the company reported stronger-than-expected results for the second quarter.

shares climbed 13.59 percent to $5.72 on better-than-expected Q2 results.

jumped 11.46 percent to $34.23 after the company reported stronger-than-expected results for the second quarter.

shares rose 10.15 percent to $46.59 after the company reported upbeat Q2 results.